Nutriband Inc. (NTRBW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.25
-2.15 (-48.86%)
At close: Jan 24, 2025, 3:34 PM
2.25
0.00%
After-hours Jan 24, 2025, 03:34 PM EST
-48.86% (1D)
Bid | 2.08 |
Market Cap | 105.72M |
Revenue (ttm) | 5.40M |
Net Income (ttm) | -18.30M |
EPS (ttm) | -0.505 |
PE Ratio (ttm) | -4.46 |
Forward PE | n/a |
Analyst | n/a |
Ask | 4 |
Volume | 33,656 |
Avg. Volume (20D) | 5,755 |
Open | 4.00 |
Previous Close | 4.40 |
Day's Range | 1.99 - 4.79 |
52-Week Range | 0.19 - 5.25 |
Beta | 0.42 |
About NTRBW
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
Website http://nutriband.com